Showing results (221-230 of 588) with videos related to
Sort By:
Pageof 59
The Biochemical Journal|October 1, 1985
Effect of 1,25-dihydroxyvitamin D3 on cyclic AMP responses to hormones in clonal osteogenic sarcoma cellsM Kubota, K W Ng, T J MartinConnective Tissue Research|January 1, 1996
Regulation of osteopontin expression by type I collagen in preosteoblastic UMR201 cellsK Traianedes, T J Martin, D M FindlayJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 1, 1993
Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized ratsD B Lauritzen, R Balena, M Shea, et al.Proceedings of the National Academy of Sciences of the United States of America|April 2, 1996
Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronateA Schmidt, S J Rutledge, N Endo, et al.The Journal of Clinical Investigation|October 1, 1983
Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cellsS B Rodan, K L Insogna, A M Vignery, et al.Clinical Endocrinology|September 1, 1978
Glucose-induced insulin secretion in patients with parathyroid disordersR V Hague, D R Cullen, T J MartinBiochemical and Biophysical Research Communications|August 16, 1984
Selective activation of cyclic AMP dependent protein kinase by calcitonin in a calcitonin secreting lung cancer cell lineJ D Zajac, S A Livesey, T J MartinCritical Reviews in Biochemistry and Molecular Biology|January 1, 1991
Parathyroid hormone-related protein: biochemistry and molecular biologyT J Martin, J M Moseley, M T GillespieOsteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 14, 2008
Regulatory pathways revealing new approaches to the development of anabolic drugs for osteoporosisT J Martin, N A Sims, K W NgPageof 59